Literature DB >> 1654525

WT1 mutations contribute to abnormal genital system development and hereditary Wilms' tumour.

J Pelletier1, W Bruening, F P Li, D A Haber, T Glaser, D E Housman.   

Abstract

Wilms' tumour (WT), aniridia, genitourinary abnormalities and mental retardation form a symptom group (WAGR syndrome) associated with hemizygous deletions of DNA in chromosome band 11p13 (refs 1,2). However, it has not been clear whether hemizygosity at a single locus contributes to more than one phenotype. The tumour suppressor gene for Wilms' tumour, WT1, has been characterized: it is expressed at high levels in the glomeruli of the kidney, as well as the gonadal ridge of the developing gonad, the Sertoli cells of the testis and the epithelial and granulosa cells of the ovary, suggesting a developmental role in the genital system in addition to the kidney. We now report constitutional mutations within the WT1 genes of two individuals with a combination of WT and genital abnormalities as evidence of a role for a recessive oncogene in mammalian development.

Entities:  

Mesh:

Year:  1991        PMID: 1654525     DOI: 10.1038/353431a0

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  93 in total

1.  A dominant mutation in the Wilms tumor gene WT1 cooperates with the viral oncogene E1A in transformation of primary kidney cells.

Authors:  D A Haber; H T Timmers; J Pelletier; P A Sharp; D E Housman
Journal:  Proc Natl Acad Sci U S A       Date:  1992-07-01       Impact factor: 11.205

2.  A single base pair polymorphism in the WT1 gene detected by single-strand conformation polymorphism analysis.

Authors:  N Groves; P N Baird; A Hogg; J K Cowell
Journal:  Hum Genet       Date:  1992-12       Impact factor: 4.132

Review 3.  PCR-SSCP: a method for the molecular analysis of genetic diseases.

Authors:  V Konstantinos Kakavas; Kakavas V Konstantinos; Panagiotis Plageras; Plageras Panagiotis; T Antonios Vlachos; Vlachos T Antonios; Agelos Papaioannou; Papaioannou Agelos; V Argiris Noulas; Noulas V Argiris
Journal:  Mol Biotechnol       Date:  2007-10-13       Impact factor: 2.695

Review 4.  Molecular determinants of sexual differentiation.

Authors:  J S Wiener; M Marcelli; D J Lamb
Journal:  World J Urol       Date:  1996       Impact factor: 4.226

5.  Inhibition of cellular proliferation by the Wilms tumor suppressor WT1 requires association with the inducible chaperone Hsp70.

Authors:  S Maheswaran; C Englert; G Zheng; S B Lee; J Wong; D P Harkin; J Bean; R Ezzell; A J Garvin; R T McCluskey; J A DeCaprio; D A Haber
Journal:  Genes Dev       Date:  1998-04-15       Impact factor: 11.361

Review 6.  Familial FSGS.

Authors:  Martin R Pollak
Journal:  Adv Chronic Kidney Dis       Date:  2014-09       Impact factor: 3.620

7.  Fine structure analysis of the WT1 gene in sporadic Wilms tumors.

Authors:  R Varanasi; N Bardeesy; M Ghahremani; M J Petruzzi; N Nowak; M A Adam; P Grundy; T B Shows; J Pelletier
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

8.  NPHS3: new clues for understanding idiopathic nephrotic syndrome.

Authors:  Bernward G Hinkes
Journal:  Pediatr Nephrol       Date:  2008-06       Impact factor: 3.714

9.  Insertional inactivation of the WT1 gene in tumour cells from a patient with WAGR syndrome.

Authors:  A Santos; L Osorio-Almeida; P N Baird; J M Silva; M G Boavida; J Cowell
Journal:  Hum Genet       Date:  1993-08       Impact factor: 4.132

10.  Exon skipping due to a mutation in a donor splice site in the WT-1 gene is associated with Wilms' tumor and severe genital malformations.

Authors:  S Schneider; G Wildhardt; R Ludwig; B Royer-Pokora
Journal:  Hum Genet       Date:  1993-07       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.